Literature DB >> 18214016

The use of solubility, dialyzability, and Caco-2 cell methods to predict iron bioavailability.

Susan Fairweather-Tait1, Ian Phillips, Gary Wortley, Linda Harvey, Ray Glahn.   

Abstract

An update on in vitro methods employed to assess iron bioavailability is presented. Solubility and dialyzability are not useful predictors of iron absorption, whereas Caco-2 cell models provide useful comparisons on the availability of iron from different sources. Strengths and weaknesses of in vitro approaches are briefly described, including the need to characterize Caco-2 cells in order to interpret results correctly. Further developments are required to refine Caco-2 model systems, including optimization and standardization of methods.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18214016     DOI: 10.1024/0300-9831.77.3.158

Source DB:  PubMed          Journal:  Int J Vitam Nutr Res        ISSN: 0300-9831            Impact factor:   1.784


  4 in total

Review 1.  Pearl millet minerals: effect of processing on bioaccessibility.

Authors:  Rateesh Krishnan; M S Meera
Journal:  J Food Sci Technol       Date:  2018-06-27       Impact factor: 2.701

2.  Effect of dephytinization on bioavailability of iron, calcium and zinc from infant cereals assessed in the Caco-2 cell model.

Authors:  Carmen Frontela; Maria-Laura Scarino; Simonetta Ferruzza; Gaspar Ros; Carmen Martínez
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

3.  Hydrophobically modified chitosan nanoliposomes for intestinal drug delivery.

Authors:  M Gulrez Zariwala; Harshada Bendre; Anatoliy Markiv; Sebastien Farnaud; Derek Renshaw; Kevin Mg Taylor; Satyanarayana Somavarapu
Journal:  Int J Nanomedicine       Date:  2018-09-27

4.  High bioavailability iron maize (Zea mays L.) developed through molecular breeding provides more absorbable iron in vitro (Caco-2 model) and in vivo (Gallus gallus).

Authors:  Elad Tako; Owen A Hoekenga; Leon V Kochian; Raymond P Glahn
Journal:  Nutr J       Date:  2013-01-04       Impact factor: 3.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.